Application 220712
- Type
- NDA
- Sponsor
- AMNEAL PHARMS NY
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | KITPROZY | CARFILZOMIB | VIAL; SINGLE-USE | 60MG/ML, 2/ML | No | No |
| 002 | KITPROZY | CARFILZOMIB | VIAL; SINGLE-USE | 120MG/2ML (60MG/ML), 2ML | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| KYPROLIS | CARFILZOMIB | Onyx Pharmaceuticals, Inc. | ea66eb30-e665-4693-99a1-a9d3b4bbe2d6 | 2025-06-18 | Warnings, Adverse reactions | CARFILZOMIB |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 85458 | ORIG | 2026-03-23 |